Roche said these high-risk farms are more likely to need animal movement controls applied to help slow the spread of the disease and speed up the eradication.
Read more articles about Mycoplasma bovis here.
New Zealand is the first country in the world to attempt to eradicate M. bovis, a bacterial disease that can cause significant animal welfare and productivity issues, particularly in dairy cattle, including mastitis that doesn't respond to treatment, severe lameness, and late term abortions.
"This research has been identified as a priority in the Mycoplasma bovis science plan, developed by the SSAG to ensure research projects are directed where they will have the most impact to accelerate eradication. It also supports recommendations made in two recent reviews into the M. bovis programme," said Roche.
This will be a short-term project based on analysis of existing data.
The M. bovis Programme has allocated up to $30 million over two years for M. bovis research projects, guided by the science plan. This is part of the $870 million in funding allocated to eradicating M. bovis.
The risk prioritisation research is the third science plan project to go out to market.
A large number of proposals for a major diagnostic research programme are currently being evaluated, submitted from researchers based in New Zealand and overseas.
Quotes to undertake a study into the direct impact of M. bovis on animals and herds are also being evaluated.
The M. bovis 'Epidemiology Research on Risk Prioritisation' request for proposals has been issued on the Government Electronic Tender Services (GETS).
Applications must be received by 2pm on 18 September 2019.
